search
Back to results

FRailty WAlking Patterns (FRAP) Study (FRAP)

Primary Purpose

Heart Failure

Status
Completed
Phase
Not Applicable
Locations
Netherlands
Study Type
Interventional
Intervention
Walking Exercises-Six Minute Walk (6MW) Test
Walking Exercises-4 Meter Gait Speed (4MGS) Test
Walking Exercises-Five Times Sit to Stand (FTSTS) Test
Walking Exercises-Expanded Timed Get-Up-and-Go (ETGUG) Test
Reveal LINQ accelerometer
3D accelerometer
Sponsored by
Medtronic BRC
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Heart Failure

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Chronic Heart Failure in New York Heart Association (NHYA) class II and class III
  • Willing to sign the informed consent form.
  • At least 18 years of age.

Exclusion Criteria:

  • • Not able to walk continuously for a period of 6 minutes and perform the walking exercises as necessary for the study protocol.

    • Any known allergy to Titanium
    • Any concomitant conditions which in the opinion of the investigator would not allow accurate measurement of gait and frailty parameters with an externally worn device.
    • Any concomitant condition which in the opinion of the investigator would not allow a safe participation in the study.
    • Enrolled in another study that could confound the results of this study, without documented pre-approval from a Medtronic study manager.

Sites / Locations

  • NUTRIM School of Nutrition and Translational Research in Metabolism of the Faculty Health, Medicine and Life Sciences, Maastricht University,

Arms of the Study

Arm 1

Arm Type

Other

Arm Label

single arm

Arm Description

Single arm, all the patients enrolled will perform the same walking exercises. On arrival to the rehabilitation center subjects will have the Reveal LINQ, the 3D-accelerometers (one on the chest by medical-grade adhesives and a second at the level of the waist over the top of a medical grade adhesive) and the Holter attached externally. Then, they will be asked to perform the following exercises: Walking Exercises-4 Meter Gait Speed (4MGS) Test Walking exercises - Six Minute Walk (6MW) Test Walking exercises - 4 Meter Gait Speed (4MGS) Test Walking Exercises - Five Times Sit to Stand (FTSTS) Test Walking Exercises - Expanded Timed Get-Up-and-Go (ETGUG) Test

Outcomes

Primary Outcome Measures

Correlation of Gait Speed Between Reveal LINQ Accelerometer, Validation Accelerometer and/or Computer Assisted Rehabilitation System by Walking Exercises
The gait speed will be calculated from the Reveal LINQ accelerometer signals, from the validation accelerometer and / or from the computer assisted rehabilitation system during the walking exercises. We will calculate the average correlation coefficient over all patients and exercises. It is reported as score on a scale, with minimum value= -1 and maximum value = 1. Higher absolute values mean higher correlation.

Secondary Outcome Measures

Full Information

First Posted
March 2, 2016
Last Updated
March 24, 2020
Sponsor
Medtronic BRC
Collaborators
Medtronic Bakken Research Center
search

1. Study Identification

Unique Protocol Identification Number
NCT02755129
Brief Title
FRailty WAlking Patterns (FRAP) Study
Acronym
FRAP
Official Title
FRailty WAlking Patterns (FRAP) Study
Study Type
Interventional

2. Study Status

Record Verification Date
March 2020
Overall Recruitment Status
Completed
Study Start Date
September 20, 2016 (Actual)
Primary Completion Date
April 20, 2017 (Actual)
Study Completion Date
July 20, 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Medtronic BRC
Collaborators
Medtronic Bakken Research Center

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The aim of this study is to evaluate sit-stand phases and gait speed detection using an externally worn Reveal LINQ (TM) compared to an external reference (3D accelerometer, and/or the Computer Assisted Rehabilitation Environment (CAREN) system) in one center in the Netherlands
Detailed Description
Frailty is a geriatric syndrome characterized by reduced homeostatic reserves, exposing the organism to extreme vulnerability to endogenous and exogenous stressors. Frailty is prevalent in older people and involves a progressive physiological decline of multiple body systems, typical signs and symptoms include weight loss, fatigue, muscle weakness, slow or unsteady gait declines in activity. Frailty is increasingly recognized as an important prognostic indicator in heart failure (HF) and is more prevalent in HF than the general population. The identification of frailty in its early stage is important because interventions may potentially prevent, or delay the clinical consequences of frailty. Of particular focus in this study will be walking speed as prior research has demonstrated that slow gait speed has the strongest prognostic ability of the traditional components used to assess frailty, and has been reported as one of the strongest to predict adverse outcomes, such as mobility disability, falls, or hospitalization. Also of interest is the detection of posture changes as this may have implications for detecting changes in sleeping habits and could also provide context for other biomarker signals collected by the LINQ device. The literature has been reviewed and the scientific soundness of the proposed analytical techniques evaluated. The rationale for this study design is to evaluate the feasibility of using the Reveal LINQ™ to monitoring walking patterns. HF patients (the target population for the study in discussion) would make it possible to test the sensitivity of the accelerometer embedded in the LINQ device in a small cohort of subjects with reduced mobility and for which frailty is more prevalent than the general population, as well as recognized as an important prognostic indicator. No risk to the subjects is expected with this study.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Heart Failure

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
15 (Actual)

8. Arms, Groups, and Interventions

Arm Title
single arm
Arm Type
Other
Arm Description
Single arm, all the patients enrolled will perform the same walking exercises. On arrival to the rehabilitation center subjects will have the Reveal LINQ, the 3D-accelerometers (one on the chest by medical-grade adhesives and a second at the level of the waist over the top of a medical grade adhesive) and the Holter attached externally. Then, they will be asked to perform the following exercises: Walking Exercises-4 Meter Gait Speed (4MGS) Test Walking exercises - Six Minute Walk (6MW) Test Walking exercises - 4 Meter Gait Speed (4MGS) Test Walking Exercises - Five Times Sit to Stand (FTSTS) Test Walking Exercises - Expanded Timed Get-Up-and-Go (ETGUG) Test
Intervention Type
Other
Intervention Name(s)
Walking Exercises-Six Minute Walk (6MW) Test
Intervention Description
The Six Minute Walk (6MW) Test measures the distance an individual is able to walk over a total of six minutes on a flat surface. The goal is for the individual to walk as far as possible in six minutes. The Six Minute Walk (6MW) test will be performed within the Computer Assisted Rehabilitation Environment (CAREN) system system environment - single arm
Intervention Type
Other
Intervention Name(s)
Walking Exercises-4 Meter Gait Speed (4MGS) Test
Intervention Description
The 4 Meter Gait Speed (4MGS) Test measures the gait speed an individual is able to walk over 4 meters on a flat surface. The goal is for the individual to walk as fast as possible over 4 meters. It will be repeated 3 times within the aforementioned 6MW test (after approximately 1, 3 and 5 minutes) to get variability due to subject tiredness. The test will be performed within the CAREN system environment. - single arm
Intervention Type
Other
Intervention Name(s)
Walking Exercises-Five Times Sit to Stand (FTSTS) Test
Intervention Description
The Five Times Sit to Stand (FTSTS) Test measures the time a subject takes to stand up from an armchair 5 times in a row, without stopping in between. It is a short test which measures dynamic balance and functional mobility - single arm
Intervention Type
Other
Intervention Name(s)
Walking Exercises-Expanded Timed Get-Up-and-Go (ETGUG) Test
Intervention Description
The Expanded Timed Get-Up-and-Go (ETGUG) Test measures the time it takes a subject to stand up from an armchair, walk a distance of 10 m, turn, walk back to the chair, and sit down. It is a short test of basic mobility skills for frail community-dwelling elderly. - single arm
Intervention Type
Other
Intervention Name(s)
Reveal LINQ accelerometer
Intervention Description
Walking exercises test
Intervention Type
Other
Intervention Name(s)
3D accelerometer
Intervention Description
Walking exercises test
Primary Outcome Measure Information:
Title
Correlation of Gait Speed Between Reveal LINQ Accelerometer, Validation Accelerometer and/or Computer Assisted Rehabilitation System by Walking Exercises
Description
The gait speed will be calculated from the Reveal LINQ accelerometer signals, from the validation accelerometer and / or from the computer assisted rehabilitation system during the walking exercises. We will calculate the average correlation coefficient over all patients and exercises. It is reported as score on a scale, with minimum value= -1 and maximum value = 1. Higher absolute values mean higher correlation.
Time Frame
During walking exercises visit, 1 Day

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Chronic Heart Failure in New York Heart Association (NHYA) class II and class III Willing to sign the informed consent form. At least 18 years of age. Exclusion Criteria: • Not able to walk continuously for a period of 6 minutes and perform the walking exercises as necessary for the study protocol. Any known allergy to Titanium Any concomitant conditions which in the opinion of the investigator would not allow accurate measurement of gait and frailty parameters with an externally worn device. Any concomitant condition which in the opinion of the investigator would not allow a safe participation in the study. Enrolled in another study that could confound the results of this study, without documented pre-approval from a Medtronic study manager.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kenneth Meijer,
Organizational Affiliation
Maastricht University
Official's Role
Principal Investigator
Facility Information:
Facility Name
NUTRIM School of Nutrition and Translational Research in Metabolism of the Faculty Health, Medicine and Life Sciences, Maastricht University,
City
Maastricht
ZIP/Postal Code
6229
Country
Netherlands

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

FRailty WAlking Patterns (FRAP) Study

We'll reach out to this number within 24 hrs